|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sinicrope FA, Okamoto K, Kasi PM and
Kawakami H: Molecular biomarkers in the personalized treatment of
colorectal cancer. Clin Gastroenterol Hepatol. 14:651–658. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lipovich L, Johnson R and Lin CY: MacroRNA
underdogs in a microRNA world: Evolutionary, regulatory and
biomedical significance of mammalian long non-protein-coding RNA.
Biochim Biophys Acta. 1799:597–615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mele M and Rinn JL: ‘Cat's cradling’ the
3D genome by the act of LncRNA transcription. Mol Cell. 62:657–664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amaral PP, Neyt C, Wilkins SJ,
Askarian-Amiri ME, Sunkin SM, Perkins AC and Mattick JS: Complex
architecture and regulated expression of the Sox2ot locus during
vertebrate development. RNA. 15:2013–2027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ravasi T, Suzuki H, Pang KC, Katayama S,
Furuno M, Okunishi R, Fukuda S, Ru K, Frith MC, Gongora MM, et al:
Experimental validation of the regulated expression of large
numbers of non-coding RNAs from the mouse genome. Genome Res.
16:11–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: LncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Slaby O: Non-coding RNAs as biomarkers for
colorectal cancer screening and early detection. Adv Exp Med Biol.
937:153–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Q, Li N, Lao Y, Lin W, Jiang G, Wei N,
Wang C, Liu K and Wu J: Variable levels of long noncoding RNA
expression in dna mismatch repair-proficient early-stage colon
cancer. Dig Dis Sci. 62:1235–1245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sawaki K, Kanda M and Kodera Y: Review of
recent efforts to discover biomarkers for early detection,
monitoring, prognosis, and prediction of treatment responses of
patients with gastric cancer. Expert Rev Gastroenterol Hepatol.
12:657–670. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu Q, Yu T, Ou X, Cao D, Xie T and Chen X:
Potential lncRNA diagnostic biomarkers for early gastric cancer.
Mol Med Rep. 16:9545–9552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shang C, Zhu W, Liu T, Wang W, Huang G,
Huang J, Zhao P, Zhao Y and Yao S: Characterization of long
non-coding RNA expression profiles in lymph node metastasis of
early-stage cervical cancer. Oncol Rep. 35:3185–3197. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A cytoplasmic NF-κB interacting
long noncoding RNA blocks IκB phosphorylation and suppresses breast
cancer metastasis. Cancer Cell. 27:370–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bian D, Gao C, Bao K and Song G: The long
non-coding RNA NKILA inhibits the invasion-metastasis cascade of
malignant melanoma via the regulation of NF-κB. Am J Cancer Res.
7:28–40. 2017.PubMed/NCBI
|
|
19
|
Lu Z, Li Y, Wang J, Che Y, Sun S, Huang J,
Chen Z and He J: Long non-coding RNA NKILA inhibits migration and
invasion of non-small cell lung cancer via NF-κB/Snail pathway. J
Exp Clin Cancer Res. 36:542017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Z, Chen Z, Li Y, Wang J, Zhang Z, Che
Y, Huang J, Sun S, Mao S, Lei Y, et al: TGF-β-induced NKILA
inhibits ESCC cell migration and invasion through NF-κB/MMP14
signaling. J Mol Med (Berl). 96:301–313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang T, Li S, Liu J, Yin D, Yang X and
Tang Q: lncRNA-NKILA/NF-κB feedback loop modulates laryngeal cancer
cell proliferation, invasion, and radioresistance. Cancer Med.
7:2048–2063. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vaiopoulos AG, Athanasoula KCh and
Papavassiliou AG: NF-κB in colorectal cancer. J Mol Med (Berl).
91:1029–1037. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pasparakis M: Role of NF-κB in epithelial
biology. Immunol Rev. 246:346–358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sunami Y and Wirth T: Intestinal
carcinogenesis: IKK can go all the way. J Clin Invest.
121:2551–2553. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maida M, Macaluso FS, Ianiro G, Mangiola
F, Sinagra E, Hold G, Maida C, Cammarota G, Gasbarrini A and
Scarpulla G: Screening of colorectal cancer: Present and future.
Expert Rev Anticancer Ther. 17:1131–1146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davies JM and Goldberg RM: Treatment of
metastatic colorectal cancer. Semin Oncol. 38:552–560. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pohl M and Schmiegel W: Colorectal
cancer-personalized, stage-adjusted tumour therapy. Dtsch Med
Wochenschr. 138:1790–1795. 2013.(In German). PubMed/NCBI
|
|
31
|
Beretta GD, Milesi L, Pessi MA, Mosconi S
and Labianca R: Adjuvant treatment of colorectal cancer. Surg
Oncol. 13:63–73. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nesbitt C, Glendinning RJ, Byrne C and
Poston GJ: Factors that influence treatment strategies in advanced
colorectal cancer. Eur J Surg Oncol. 33 (Suppl 2):S88–S94. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nguyen HT and Duong HQ: The molecular
characteristics of colorectal cancer: Implications for diagnosis
and therapy. Oncol Lett. 16:9–18. 2018.PubMed/NCBI
|
|
34
|
Heiss JA and Brenner H: Epigenome-wide
discovery and evaluation of leukocyte DNA methylation markers for
the detection of colorectal cancer in a screening setting. Clin
Epigenetics. 9:242017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vatandoost N, Ghanbari J, Mojaver M, Avan
A, Ghayour-Mobarhan M, Nedaeinia R and Salehi R: Early detection of
colorectal cancer: From conventional methods to novel biomarkers. J
Cancer Res Clin Oncol. 142:341–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Link A, Balaguer F, Shen Y, Nagasaka T,
Lozano JJ, Boland CR and Goel A: Fecal MicroRNAs as novel
biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers
Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pellino G, Gallo G, Pallante P, Capasso R,
De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A,
et al: Noninvasive biomarkers of colorectal cancer: Role in
diagnosis and personalised treatment perspectives. Gastroenterol
Res Pract. 2018:23978632018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nikolaou S, Qiu S, Fiorentino F, Rasheed
S, Tekkis P and Kontovounisios C: Systematic review of blood
diagnostic markers in colorectal cancer. Tech Coloproctol.
22:481–498. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Young GP, Pedersen SK, Mansfield S, Murray
DH, Baker RT, Rabbitt P, Byrne S, Bambacas L, Hollington P and
Symonds EL: A cross-sectional study comparing a blood test for
methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection
of recurrent colorectal cancer. Cancer Med. 5:2763–2772. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F,
Zhuo C, Zheng Y, Li B, Wang Z and Xu Y: Nuclear-enriched abundant
transcript 1 as a diagnostic and prognostic biomarker in colorectal
cancer. Mol Cancer. 14:1912015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu W, Chen F, Cui X, Yang L, Chen J, Zhao
J, Huang D, Liu J, Yang L, Zeng J, et al: LncRNA NKILA suppresses
TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB
Signaling in breast cancer. Int J Cancer. 143:2213–2224. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu X, Tang W, Yang Y, Tang L, Dai R, Pu B,
Feng C and Xia J: Long noncoding RNA NKILA enhances the anti-cancer
effects of baicalein in hepatocellular carcinoma via the regulation
of NF-κB signaling. Chem Biol Interact. 285:48–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
